Medicine and Dentistry
Cohort Analysis
100%
Disability Pension
40%
Work Disability
40%
Hazard Ratio
26%
Vincristine
24%
Arsenic Trioxide
20%
Acute Promyelocytic Leukemia
20%
Peripheral Neuropathy
20%
Acute Lymphoblastic Leukemia
20%
Alzheimer's Disease
20%
Silo-Filler's Disease
20%
Classical Hodgkin Lymphoma
20%
Chemotherapy-Induced Peripheral Neuropathy
20%
Lenalidomide
20%
Bortezomib
20%
Chronic Myelogenous Leukemia
20%
Work Capacity
20%
Malignant Neoplasm
13%
Population
13%
Bleomycin
11%
Childbirth
10%
Charlson Comorbidity Index
10%
Tretinoin
8%
Doxorubicin
8%
Interstitial Lung Disease
8%
Attributable Risk
6%
Clinician
6%
Central Nervous System
5%
Drug Therapy
5%
Keyphrases
National Cohort Study
40%
Lymphoma
40%
Population-based Study
24%
Danish Population
24%
Classical Hodgkin Lymphoma
22%
Return to Work
20%
Work Disability
20%
Chemotherapy-induced Peripheral Neuropathy
20%
Hermeneutic Phenomenology
20%
Survivor Experience
20%
Pulmonary Disease
20%
Everyday Life
20%
Background Population
20%
Haematological Cancer Survivors
20%
Migrant Patients
20%
Non-Western Immigrants
20%
Disability Pension
17%
Overall Survival
17%
Bleomycin
11%
Flexible Jobs
11%
Immigration Status
8%
Excess Risk
8%
Cumulative Risk
8%
Interstitial Lung Disease
8%
High Risk
5%
Risk Difference
5%
Retirement Pension
5%
Confidence Interval
5%
Sick Leave
5%
Complete Remission
5%
Impact of Immigration
5%
Low Socioeconomic Status
5%
Pharmacology, Toxicology and Pharmaceutical Science
Cohort Study
63%
Classical Hodgkin Lymphoma
23%
Overall Survival
22%
Arsenite
20%
Work Disability
20%
Peripheral Neuropathy
20%
Acute Lymphoblastic Leukemia
20%
Promyelocytic Leukemia
20%
Alzheimer's Disease
20%
Lenalidomide
20%
Bortezomib
20%
Chemotherapy-Induced Peripheral Neuropathy
20%
Vincristine
20%
Chronic Myeloid Leukemia
20%
Malignant Neoplasm
14%
Remission
10%
Retinoic Acid
8%
Comorbidity
7%
Chemotherapy
7%
